|
ARQT | Arcutis Biotherapeutics, Inc. |
|
|
ARQT | Arcutis Biotherapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.16 |
| Leverage | 64.18% |
| Market Cap | $ 976.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -193.4m |
| Margin | -131.76% |
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California.